|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Altus Biologics Inc., of Cambridge, Mass., said a study demonstrating the applicability of its protein crystallization drug delivery technology, Crystalomics, to the delivery and large-scale development of monoclonal antibodies was published in the current issue of Proceedings of the National Academy of Sciences. The results of the study indicate that high-concentration, low-viscosity crystalline suspensions provide an improved product and method for delivery of MAbs, Altus said.
o Argenta Discovery Ltd., of Harlow, UK, entered a collaboration with Teijin Ltd., of Tokyo. Argenta will exploit a range of approaches to deliver an optimized lead series against a ...